Biota Pharmaceuticals Inc (BOTA)

1.36
0.02 1.49
NASDAQ : Health Care
Prev Close 1.34
Open 1.35
Day Low/High 1.34 / 1.36
52 Wk Low/High 1.23 / 2.66
Volume 38.69K
Avg Volume 36.10K
Exchange NASDAQ
Shares Outstanding 38.64M
Market Cap 59.89M
EPS -0.54
Div & Yield N.A. (N.A)

Latest News

Biota Announces Positive Results From Phase 1 Program For Direct Acting RSV Antiviral BTA585

Biota Announces Positive Results From Phase 1 Program For Direct Acting RSV Antiviral BTA585

Phase 2a RSV Challenge Study Planned for Q2 2016

Biota Pharmaceuticals Reports Second Quarter Fiscal Year 2016 Financial Results

Biota Pharmaceuticals Reports Second Quarter Fiscal Year 2016 Financial Results

Conference Call to be Held Today at 9:00 A.M. EST

Biota Announces Positive Phase 1 Data For Direct-Acting RSV Antiviral BTA585 

Biota Announces Positive Phase 1 Data For Direct-Acting RSV Antiviral BTA585 

Commences Dosing in Phase 1 Multiple Ascending Dose Study with Top-Line Data Expected in 1H 2016

Nov. 6 Premarket Briefing: 10 Things You Should Know

Nov. 6 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are mixed and not moving much as investors gear up for the all-important jobs report Friday morning.

BIOTA ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Continues Investigation Of Biota Pharmaceuticals, Inc.; Investors Encouraged To Contact The Firm

BIOTA ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Continues Investigation Of Biota Pharmaceuticals, Inc.; Investors Encouraged To Contact The Firm

Shareholder rights law firm Johnson & Weaver, LLP continues its investigation into whether certain officers and directors of Biota Pharmaceuticals, Inc, (Nasdaq: BOTA) violated state or federal laws.

Insider Trading Alert - CVGW, BOTA And FGP Traded By Insiders

Insider Trading Alert - CVGW, BOTA And FGP Traded By Insiders

Stocks with insider trader activity include CVGW, BOTA and FGP

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CNTY, NCR, RJET, TRT Downgrades: ABEV, BOTA, DTSI, FSLR, L, LE, MWE, VRNT Initiations: CIO, CMFN Read on to get TheStreet Quant Ratings' detailed report:

Biota Pharmaceuticals Completes Acquisition Of Anaconda Pharma

Biota Pharmaceuticals Completes Acquisition Of Anaconda Pharma

Phase 2 for Trial for AP611074 in Patients With Anogenital Warts Planned for Late 2015

Insider Trading Alert - LLY, BOTA And NWY Traded By Insiders

Insider Trading Alert - LLY, BOTA And NWY Traded By Insiders

Stocks with insider trader activity include LLY, BOTA and NWY